Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune markers in hematologic malignancies.

L Vaickus1, E D Ball, K A Foon

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263.

Critical Reviews in Oncology/Hematology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple qualitive procedure for the detection of chloroquine in urine for use in clinical analytical toxicology in resource poor settings.

The Central African journal of medicine·2017
Same author

Methods for Retrovirus-Mediated Gene Transfer to CD34(+) Enriched Cells.

Methods in molecular medicine·2014
Same author

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.

Bone marrow transplantation·2012
Same author

Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.

International journal of breast cancer·2012
Same author

Changing paradigms in the treatment of chronic lymphocytic leukemia.

Leukemia·2009
Same author

Optimal use of G-CSF administration after hematopoietic SCT.

Bone marrow transplantation·2009
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: implications for tumor biology and therapeutic strategies - a comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative Splicing in Breast Cancer Drug Resistance: Mechanisms, Therapeutic Targeting, and Clinical Translation.

Critical reviews in oncology/hematology·2026
Same journal

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Critical reviews in oncology/hematology·2026
Same journal

Opportunities and Challenges of Dihydrodiol dehydrogenase Expression in Hepatocellular carcinoma.

Critical reviews in oncology/hematology·2026
Same journal

Ferroptosis in glioblastoma: Molecular determinants, immune crosstalk, and therapeutic opportunities.

Critical reviews in oncology/hematology·2026
See all related articles

Distinguishing normal from malignant hematopoietic cells is crucial for understanding hematologic malignancies. Advanced techniques like flow cytometry and molecular analysis aid in diagnosis, prognosis, and treatment.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Understanding the biological differences between normal and malignant hematopoietic cells is fundamental to hematologic malignancy research.
  • Hematologic malignancies encompass a range of blood cancers requiring precise characterization.

Purpose of the Study:

  • To highlight the importance of distinguishing normal from malignant hematopoietic cells.
  • To review the technological advancements used in this differentiation process.
  • To emphasize the role of these distinctions in the diagnosis, prognosis, and treatment of hematologic malignancies.

Main Methods:

  • Utilizing monoclonal antibodies with immunoperoxidase, immunoalkaline phosphatase, and flow cytometry.
  • Employing molecular biology techniques such as Southern blot, Northern blot, and polymerase chain reaction (PCR).

Related Experiment Videos

Main Results:

  • These methods effectively differentiate normal hematopoietic cells from malignant ones.
  • Characterization of malignant clones as B-lymphoid, T-lymphoid, or myeloid is achieved.
  • Further subcategorization within these lineages is possible.

Conclusions:

  • Technological advancements have significantly improved the ability to distinguish and characterize hematopoietic cells.
  • Accurate cell identification is vital for basic research and clinical applications in hematologic malignancies.
  • These distinctions play an increasingly critical role in the diagnosis, prognosis, and treatment strategies for blood cancers.